ATMRD 2024

Hallucinations and delusions are common, underreported nonmotor symptoms of Parkinson’s disease (PD) that significantly impact patients and their caregivers. Attempting to manage hallucinations and delusions in patients with PD can present a therapeutic bind. Join Neal Hermanowicz, MD, FAAN, and Sherrie Gould, MSN, NP-C for an interactive presentation exploring these challenges as well as a review of the clinical efficacy and safety of a treatment option. Additionally, real-world evidence from 2 retrospective analyses investigating the risk of all-cause mortality among patients with PD psychosis treated with atypical antipsychotics will be presented.  

---

Parkinson and Movement Disorder Alliance (PMD Alliance) has agreed to share information on this non-CME activity. The program was not produced, nor subject to review, by PMD Alliance and is not part of the continuing medical education program offered by PMD Alliance.  PMD Alliance does not endorse the specific product or message presented.  PMD Alliance will never share your name, e-mail, or other contact information with sponsors without your consent.